BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 6449567)

  • 21. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
    Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
    Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient accumulation of Tc 99m MDP in the liver.
    Dudczak R; Angelberger P; Kletter K; Frischauf H
    Eur J Nucl Med; 1980 Apr; 5(2):189-91. PubMed ID: 6445828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A crossover study comparing Tc-99m-labeled HMDP and MDP in patients.
    Rosenthall L; Arzoumanian A; Damtew BU; Tremblay J
    Clin Nucl Med; 1981 Aug; 6(8):353-5. PubMed ID: 6455231
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
    Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
    Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
    [No Abstract]   [Full Text] [Related]  

  • 26. [Accumulation of sodium 2,3-dicarboxypropan-1,1-diphosphonate in bone of rabbits (author's transl)].
    Nagai K; Otsuka N; Terashima H; Yanagimoto S; Nagase N; Muranaka A; Ito Y
    Radioisotopes; 1982 Apr; 31(4):197-8. PubMed ID: 6213983
    [No Abstract]   [Full Text] [Related]  

  • 27. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
    Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
    J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of technetium-99m methylene diphosphonate. Conditions affecting adsorption to hydroxyapatite.
    Okamoto Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jul; 80(1):115-9. PubMed ID: 7552850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
    Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
    Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
    [No Abstract]   [Full Text] [Related]  

  • 33. Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.
    Makris G; Tseligka ED; Pirmettis I; Papadopoulos MS; Vizirianakis IS; Papagiannopoulou D
    Mol Pharm; 2016 Jul; 13(7):2301-17. PubMed ID: 27170456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative.
    Lin J; Qiu L; Cheng W; Luo S; Ye W
    Nucl Med Biol; 2011 Jul; 38(5):619-29. PubMed ID: 21718936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
    Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
    Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
    [No Abstract]   [Full Text] [Related]  

  • 39. Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.
    Fogelman I; Greig WR; Bessent RG; Boyle IT
    J Nucl Med; 1977 Oct; 18(10):1040-1. PubMed ID: 409748
    [No Abstract]   [Full Text] [Related]  

  • 40. [An evaluation of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) as a new bone scanning agent (author's transl)].
    Hayashi M; Takahashi K; Furukawa K; Hazue M; Shibatsuji H; Yasuda N; Tanaka K; Yoshikawa I; Maeda K; Hamada S
    Radioisotopes; 1981 Jan; 30(1):38-9. PubMed ID: 7268059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.